Literature DB >> 6500575

The frequency of 47,+21,47,+18, and 47,+13 at the uppermost extremes of maternal ages: results on 56,094 fetuses studied prenatally and comparisons with data on livebirths.

E B Hook, P K Cross, R R Regal.   

Abstract

We examined the proportions (or so called "rates") of fetuses with 47,+21, 47,+18, or 47,+13 diagnosed prenatally in women at the upper extremes of age. Our analysis was prompted by results from a large scale European study of amniocentesis which indicated that after increasing exponentially from age 35 years, the proportions of the autosomal trisomies reached a peak at a specific age and then leveled off or declined at the upper end of the age range. We analyzed North American data on 56,075 fetuses studied because of no known cytogenetic risk factor (aside from maternal age). This is the largest series to date. For 47,+21, the data from amniocentesis studies provide no evidence for any drop in the rate of change of proportion with maternal age up to 49 years. There is, if anything, a trend in our data to a steepening in the exponential rate of change at the upper extreme of age (above 46 years). Data from livebirths on the Down syndrome phenotype are at least consistent with an exponential rate of increase in proportion affected up to age 49 years. For 47,+18 our data from prenatal diagnoses are more consistent with an exponential increase up to age 43 years and a level proportion (or "rate") after that. For 47,+13 no cases were observed above age 42 years, consistent with the drop in proportion affected above this age observed in the European series. We emphasize the possible effect of sampling fluctuation and reporting error upon these apparent trends.

Entities:  

Mesh:

Year:  1984        PMID: 6500575     DOI: 10.1007/bf00418391

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  17 in total

1.  Definition of rates: some remarks on their use and misuse.

Authors:  R C Elandt-Johnson
Journal:  Am J Epidemiol       Date:  1975-10       Impact factor: 4.897

2.  Frequency of Down syndrome in livebirths by single-year maternal age interval: results of a Massachusetts study.

Authors:  E B Hook; J J Fabia
Journal:  Teratology       Date:  1978-06

3.  Estimated rates of Down syndrome in live births by one year maternal age intervals for mothers aged 20-49 in a New York State study-implications of the risk figures for genetic counseling and cost-benefit analysis of prenatal diagnosis programs.

Authors:  E B Hook; G M Chambers
Journal:  Birth Defects Orig Artic Ser       Date:  1977

4.  Down syndrome in live births by single year maternal age interval in a Swedish study: comparison with results from a New York State study.

Authors:  E B Hook; A Lindsjö
Journal:  Am J Hum Genet       Date:  1978-01       Impact factor: 11.025

5.  Rates of trisomy 18 in livebirths, stillbirths, and at amniocentesis.

Authors:  E B Hook; D F Woodbury; S G Albright
Journal:  Birth Defects Orig Artic Ser       Date:  1979

6.  Rates of trisomies 21, 18, 13 and other chromosome abnormalities in about 20 000 prenatal studies compared with estimated rates in live births.

Authors:  D M Schreinemachers; P K Cross; E B Hook
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

7.  Comparison of mathematical models for the maternal age dependence of Down's syndrome rates.

Authors:  S H Lamson; E B Hook
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

8.  Down's syndrome: percentage reporting on birth certificates and single year maternal age risk rates for Ohio 1970-79: comparison with upstate New York data.

Authors:  C A Huether; G R Gummere; E B Hook; P S Dignan; H Volodkevich; M Barg; D A Ludwig; S H Lamson
Journal:  Am J Public Health       Date:  1981-12       Impact factor: 9.308

9.  Down's syndrome in Wallonia (South Belgium), 1971-1978: cytogenetics and incidence.

Authors:  L Koulischer; Y Gillerot
Journal:  Hum Genet       Date:  1980       Impact factor: 4.132

10.  Chromosomal abnormality rates at amniocentesis and in live-born infants.

Authors:  E B Hook; P K Cross; D M Schreinemachers
Journal:  JAMA       Date:  1983-04-15       Impact factor: 56.272

View more
  8 in total

1.  International variation in reported livebirth prevalence rates of Down syndrome, adjusted for maternal age.

Authors:  A D Carothers; C A Hecht; E B Hook
Journal:  J Med Genet       Date:  1999-05       Impact factor: 6.318

2.  AluI-resistant chromatin of chromosome 18: classification, frequencies and implications.

Authors:  A Babu; R S Verma; S R Patil
Journal:  Chromosoma       Date:  1987       Impact factor: 4.316

3.  The heteromorphic marker on chromosome 18 using restriction endonuclease AluI.

Authors:  A Babu; R S Verma
Journal:  Am J Hum Genet       Date:  1986-04       Impact factor: 11.025

4.  An analysis of paternal age and 47,+21 in 35,000 new prenatal cytogenetic diagnosis data from the New York State Chromosome Registry: no significant effect.

Authors:  P K Cross; E B Hook
Journal:  Hum Genet       Date:  1987-12       Impact factor: 4.132

5.  Trisomy 13 ascertained in a survey of spontaneous abortions.

Authors:  P A Jacobs; T J Hassold; A Henry; D Pettay; N Takaesu
Journal:  J Med Genet       Date:  1987-12       Impact factor: 6.318

6.  Extra structurally abnormal chromosomes (ESAC) detected at amniocentesis: frequency in approximately 75,000 prenatal cytogenetic diagnoses and associations with maternal and paternal age.

Authors:  E B Hook; P K Cross
Journal:  Am J Hum Genet       Date:  1987-02       Impact factor: 11.025

7.  Maternal age-specific rates of 47,+21 and other cytogenetic abnormalities diagnosed in the first trimester of pregnancy in chorionic villus biopsy specimens: comparison with rates expected from observations at amniocentesis.

Authors:  E B Hook; P K Cross; L Jackson; E Pergament; B Brambati
Journal:  Am J Hum Genet       Date:  1988-06       Impact factor: 11.025

8.  Mortality among infants with congenital malformations, New York State, 1983 to 1988.

Authors:  C Druschel; J P Hughes; C Olsen
Journal:  Public Health Rep       Date:  1996 Jul-Aug       Impact factor: 2.792

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.